Transport Mechanisms of Solid Lipid Nanoparticles across Caco-2 Cell Monolayers and their Related Cytotoxicology

Gui-Hong Chai1, Yingke Xu2, Shao-Qing Chen1

  • 1Institute of Pharmaceutics, Zhejiang University , 866 Yuhangtang Road, Hangzhou 310058, China.

Insights

Solid lipid nanoparticles (SLNs) are promising oral drug carriers. This study reveals SLNs are transported via vesicle-mediated endocytosis, utilizing macropinocytosis and clathrin/caveolae pathways, without damaging intestinal cells.

Area of Science:

  • Nanotechnology
  • Pharmacology
  • Cell Biology

Background:

  • Solid lipid nanoparticles (SLNs) show potential for enhancing oral drug bioavailability.
  • The precise molecular mechanisms of SLN intestinal transport remain largely unknown.
  • Understanding SLN interactions with intestinal epithelial cells is crucial for drug delivery applications.

Purpose of the Study:

  • To elucidate the molecular transport mechanisms of SLNs across Caco-2 intestinal epithelial cell monolayers.
  • To investigate the safety and cellular fate of SLNs following intestinal cell interaction.

Main Methods:

  • Cytotoxicity assays on Caco-2 cells to assess SLN safety.
  • Time- and energy-dependency studies for SLN endocytosis.
  • Investigation of endocytic pathways (clathrin, caveolae, macropinocytosis) and cellular destinations (endosomes, lysosomes, ER, Golgi).
  • Analysis of SLN integrity and tight junction structure during transcytosis.

Main Results:

  • SLNs exhibited low cytotoxicity, preserved cell membrane integrity, and reduced membrane fluidity.
  • SLN uptake was time- and energy-dependent, occurring via vesicle-mediated endocytosis (macropinocytosis, clathrin-, caveolae-related routes).
  • SLNs were trafficked to transferrin-related endosomes, lysosomes, ER, and Golgi; transcytosis maintained SLN integrity and tight junction structure.

Conclusions:

  • SLN transport across intestinal monolayers is a vesicle-mediated process involving multiple endocytic pathways.
  • SLNs are safely internalized and transported intact across the intestinal epithelium, with ER, Golgi, and microtubules playing key roles.
  • This research provides critical insights into SLN intestinal transport mechanisms, aiding in the rational design of SLN-based oral drug delivery systems.

Related Concept Videos

Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
2.0K
Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport01:23

Mechanisms of Drug Absorption: Paracellular, Transcellular, and Vesicular Transport

Drugs need to permeate cell membranes to reach their target sites after administration. Orally administered drugs must transcend intestinal epithelial membrane barriers to infiltrate the systemic circulation. Drugs with a molecular weight of less than 500 Daltons diffuse through gaps between neighboring cells, called paracellular pathways.
However, most drugs use the transcellular route, traversing directly through the cell membranes via two mechanisms: passive and active transport. Passive...
2.4K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
1.5K
Drug Absorption Mechanism: Passive Membrane Transport01:23

Drug Absorption Mechanism: Passive Membrane Transport

Passive transport is a method of drug absorption where small, lipid-soluble drugs can move across the cell membrane. This movement happens along the concentration gradient, which is a natural flow from higher to lower concentration areas. The speed at which the drug moves is directly related to its lipid–water partition coefficient. This means that the more a drug dissolves in lipids, the faster it diffuses or spreads throughout the body. It is important to note that most drugs are either...
7.8K
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
299
Methods for Studying Drug Absorption: In vitro01:16

Methods for Studying Drug Absorption: In vitro

In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
739